Sheila V. Clark

Array ( [id] => 8772517 [patent_doc_number] => 08426473 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-04-23 [patent_title] => 'Phenoxy acetic acids as PPAR delta activators' [patent_app_type] => utility [patent_app_number] => 13/466191 [patent_app_country] => US [patent_app_date] => 2012-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52966 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13466191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8566010 [patent_doc_number] => 20120328580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-27 [patent_title] => 'COMPOUNDS THAT ENHANCE ATOH1 EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/454702 [patent_app_country] => US [patent_app_date] => 2012-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 87 [patent_figures_cnt] => 87 [patent_no_of_words] => 33985 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13454702 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8618152 [patent_doc_number] => 20130023463 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'HIV PROTEASE INHIBITING COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/451370 [patent_app_country] => US [patent_app_date] => 2012-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 167840 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13451370 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8336073 [patent_doc_number] => 20120202779 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'MANAGEMENT OF BREAKTHROUGH BLEEDING IN EXTENDED HORMONAL CONTRACEPTIVE REGIMENS' [patent_app_type] => utility [patent_app_number] => 13/448585 [patent_app_country] => US [patent_app_date] => 2012-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5045 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13448585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8453874 [patent_doc_number] => 20120264821 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'USE OF EQUOL FOR TREATING ANDROGEN MEDIATED DISEASES' [patent_app_type] => utility [patent_app_number] => 13/442466 [patent_app_country] => US [patent_app_date] => 2012-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 17575 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13442466 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9363782 [patent_doc_number] => 20140073655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-13 [patent_title] => 'METHOD FOR TREATING FATIGUE' [patent_app_type] => utility [patent_app_number] => 14/009102 [patent_app_country] => US [patent_app_date] => 2012-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4336 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14009102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9223664 [patent_doc_number] => 20140018439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'Weather-Resistant Pearlescent Pigments, Process for the Production and Use Thereof' [patent_app_type] => utility [patent_app_number] => 14/007383 [patent_app_country] => US [patent_app_date] => 2012-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9073 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14007383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9396159 [patent_doc_number] => 20140093565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-04-03 [patent_title] => 'A PHARMACEUTICAL COMPOSITION COMPRISING A HDAC INHIBITOR AND A STEROID AND THE USE THEREOF' [patent_app_type] => utility [patent_app_number] => 14/005933 [patent_app_country] => US [patent_app_date] => 2012-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6507 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14005933 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9295333 [patent_doc_number] => 20140038967 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'NOVEL USE FOR IMIDAZOTRIAZINONES' [patent_app_type] => utility [patent_app_number] => 14/004154 [patent_app_country] => US [patent_app_date] => 2012-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10322 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14004154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10648225 [patent_doc_number] => 09364452 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-14 [patent_title] => 'Pharmaceutical composition for preventing or treating hepatic fibrosis and cirrhosis containing ramalin' [patent_app_type] => utility [patent_app_number] => 14/381490 [patent_app_country] => US [patent_app_date] => 2012-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 5617 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14381490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8371168 [patent_doc_number] => 20120220557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-30 [patent_title] => 'LIQUID PROPELLANT-FREE FORMULATION COMPRISING AN ANTIMUSCARINIC DRUG' [patent_app_type] => utility [patent_app_number] => 13/370380 [patent_app_country] => US [patent_app_date] => 2012-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5615 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13370380 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9223563 [patent_doc_number] => 20140018338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'METHODS AND ASSAYS FOR TREATING FILOVIRIDAE INFECTIONS' [patent_app_type] => utility [patent_app_number] => 13/979179 [patent_app_country] => US [patent_app_date] => 2012-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 21695 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979179 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8858677 [patent_doc_number] => 08461212 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-11 [patent_title] => 'Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/345979 [patent_app_country] => US [patent_app_date] => 2012-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 33 [patent_no_of_words] => 19757 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13345979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9703962 [patent_doc_number] => 08829024 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-09 [patent_title] => 'Combination steroid and glucocorticoid receptor antagonist therapy' [patent_app_type] => utility [patent_app_number] => 13/345242 [patent_app_country] => US [patent_app_date] => 2012-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 8896 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13345242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8642708 [patent_doc_number] => 08367693 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-02-05 [patent_title] => 'Opioid salts and formulations exhibiting anti-abuse anti-dose dumping properties' [patent_app_type] => utility [patent_app_number] => 13/339456 [patent_app_country] => US [patent_app_date] => 2011-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 105 [patent_figures_cnt] => 105 [patent_no_of_words] => 28158 [patent_no_of_claims] => 132 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13339456 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8571798 [patent_doc_number] => 08338444 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2012-12-25 [patent_title] => 'Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties' [patent_app_type] => utility [patent_app_number] => 13/338459 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 105 [patent_figures_cnt] => 105 [patent_no_of_words] => 28137 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 463 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13338459 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9113158 [patent_doc_number] => 08569330 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2013-10-29 [patent_title] => 'Opioid salts and formulations exhibiting anti-abuse and anti-dose dumping properties' [patent_app_type] => utility [patent_app_number] => 13/338329 [patent_app_country] => US [patent_app_date] => 2011-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 105 [patent_figures_cnt] => 105 [patent_no_of_words] => 28143 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13338329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8264654 [patent_doc_number] => 20120164082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'METHOD OF USING APPARATUS FOR PREVENTING PLAQUE, PREVENTING CATIVIES AND KEEPING TEETH CLEAN' [patent_app_type] => utility [patent_app_number] => 13/333917 [patent_app_country] => US [patent_app_date] => 2011-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1172 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13333917 [rel_patent_id] =>[rel_patent_doc_number] =>)